GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » PS Ratio

Allurion Technologies (Allurion Technologies) PS Ratio : 1.63 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Allurion Technologies's share price is $1.96. Allurion Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.21. Hence, Allurion Technologies's PS Ratio for today is 1.63.

Good Sign:

Allurion Technologies Inc stock PS Ratio (=1.3) is close to 1-year low of 1.3

The historical rank and industry rank for Allurion Technologies's PS Ratio or its related term are showing as below:

ALUR' s PS Ratio Range Over the Past 10 Years
Min: 1.45   Med: 2.59   Max: 4.29
Current: 1.63

During the past 3 years, Allurion Technologies's highest PS Ratio was 4.29. The lowest was 1.45. And the median was 2.59.

ALUR's PS Ratio is ranked better than
68.36% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 3.28 vs ALUR: 1.63

Allurion Technologies's Revenue per Sharefor the three months ended in Dec. 2023 was $0.17. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.21.

During the past 12 months, the average Revenue per Share Growth Rate of Allurion Technologies was 8.80% per year.

Back to Basics: PS Ratio


Allurion Technologies PS Ratio Historical Data

The historical data trend for Allurion Technologies's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies PS Ratio Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23
PS Ratio
- - 2.49

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only - - - 2.97 2.49

Competitive Comparison of Allurion Technologies's PS Ratio

For the Medical Devices subindustry, Allurion Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's PS Ratio distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's PS Ratio falls into.



Allurion Technologies PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Allurion Technologies's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.96/1.206
=1.63

Allurion Technologies's Share Price of today is $1.96.
Allurion Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Allurion Technologies  (NYSE:ALUR) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Allurion Technologies PS Ratio Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Allurion Technologies (Allurion Technologies) Business Description

Traded in Other Exchanges
N/A
Address
11 Huron Drive, Natick, MA, USA, 01760
Website
Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Executives
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta director, 10 percent owner 307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth officer: Chief Financial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin director C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson director 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon officer: Chief Commercial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur director, officer: Chief Executive Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani officer: Chief Medical Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760